KLF6-mediated Recruitment of the P300 Complex Enhances H3K23su and Cooperatively Upregulates SEMA3C with FOSL2 to Drive 5-FU Resistance in Colon Cancer Cells

Overview

Journal Exp Mol Med

Specialties Biochemistry
Molecular Biology

Date 2025 Mar 14

PMID 40082673

Authors

Bishu Zhang

Tuoya Qi

Jiewei Lin

Shuyu Zhai

Xuelong Wang

Leqi Zhou

Xiaxing Deng

Affiliations

Soon will be listed here.

Abstract

Histone lysine succinylation, an emerging epigenetic marker, has been implicated in diverse cellular functions, yet its role in cancer drug resistance is not well understood. Here we investigated the genome-wide alterations in histone 3 lysine 23 succinylation (H3K23su) and its impact on gene expression in 5-fluorouracil (5-FU)-resistant HCT15 colon cancer cells. We utilized CUT&Tag assays to identify differentially enriched regions (DERs) of H3K23su in 5-FU-resistant HCT15 cells via integration with ATAC-seq and RNA sequencing data. The regulatory network involving transcription factors (TFs), notably FOSL2 and KLF6, and their downstream target genes was dissected using motif enrichment analysis and chromatin immunoprecipitation assays. Our results revealed a strong positive correlation between H3K23su DERs, differentially expressed genes (DEGs) and H3K27ac, indicating that H3K23su enrichment is closely related to gene activation. The DEGs associated with the H3K23su GAIN regions were significantly enriched in pathways related to colorectal cancer, including the Wnt, MAPK and p53 signaling pathways. FOSL2 and KLF6 emerged as pivotal TFs potentially modulating DEGs associated with H3K23su DERs and were found to be essential for sustaining 5-FU resistance. Notably, we discovered that FOSL2 and KLF6 recruit the PCAF-p300/CBP complex to synergistically regulate SEMA3C expression, which subsequently modulates the canonical Wnt-β-catenin signaling pathway, leading to the upregulation of MYC and FOSL2. This study demonstrated that H3K23su is a critical epigenetic determinant of 5-FU resistance in colon cancer cells, exerting its effects through the modulation of critical genes and TFs. These findings indicate that interventions aimed at targeting TFs or enzymes involved in H3K23su modification could represent potential therapeutic strategies for treating colorectal cancers that are resistant to 5-FU treatment.

References

Dekker E, Tanis P, Vleugels J, Kasi P, Wallace M . Colorectal cancer. Lancet. 2019; 394(10207):1467-1480. DOI: 10.1016/S0140-6736(19)32319-0. View

Sung H, Ferlay J, Siegel R, Laversanne M, Soerjomataram I, Jemal A . Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021; 71(3):209-249. DOI: 10.3322/caac.21660. View

Hu T, Li Z, Gao C, Cho C . Mechanisms of drug resistance in colon cancer and its therapeutic strategies. World J Gastroenterol. 2016; 22(30):6876-89. PMC: 4974586. DOI: 10.3748/wjg.v22.i30.6876. View

Marmol I, Sanchez-de-Diego C, Pradilla Dieste A, Cerrada E, Rodriguez Yoldi M . Colorectal Carcinoma: A General Overview and Future Perspectives in Colorectal Cancer. Int J Mol Sci. 2017; 18(1). PMC: 5297828. DOI: 10.3390/ijms18010197. View

Longley D, Harkin D, Johnston P . 5-fluorouracil: mechanisms of action and clinical strategies. Nat Rev Cancer. 2003; 3(5):330-8. DOI: 10.1038/nrc1074. View

Vodenkova S, Buchler T, Cervena K, Veskrnova V, Vodicka P, Vymetalkova V . 5-fluorouracil and other fluoropyrimidines in colorectal cancer: Past, present and future. Pharmacol Ther. 2019; 206:107447. DOI: 10.1016/j.pharmthera.2019.107447. View

Sethy C, Kundu C . 5-Fluorouracil (5-FU) resistance and the new strategy to enhance the sensitivity against cancer: Implication of DNA repair inhibition. Biomed Pharmacother. 2021; 137:111285. DOI: 10.1016/j.biopha.2021.111285. View

Liu J, Huang Y, Wang H, Wu D . MiR-106a-5p promotes 5-FU resistance and the metastasis of colorectal cancer by targeting TGFβR2. Int J Clin Exp Pathol. 2020; 11(12):5622-5634. PMC: 6963073. View

Lai Q, Li Q, He C, Fang Y, Lin S, Cai J . CTCF promotes colorectal cancer cell proliferation and chemotherapy resistance to 5-FU via the P53-Hedgehog axis. Aging (Albany NY). 2020; 12(16):16270-16293. PMC: 7485712. DOI: 10.18632/aging.103648. View

10.

Zhu Y, Hu H, Yuan Z, Zhang Q, Xiong H, Hu Z . LncRNA NEAT1 remodels chromatin to promote the 5-Fu resistance by maintaining colorectal cancer stemness. Cell Death Dis. 2020; 11(11):962. PMC: 7653927. DOI: 10.1038/s41419-020-03164-8. View

11.

Zhang Z, Tan M, Xie Z, Dai L, Chen Y, Zhao Y . Identification of lysine succinylation as a new post-translational modification. Nat Chem Biol. 2010; 7(1):58-63. PMC: 3065206. DOI: 10.1038/nchembio.495. View

12.

Liu J, Shangguan Y, Tang D, Dai Y . Histone succinylation and its function on the nucleosome. J Cell Mol Med. 2021; 25(15):7101-7109. PMC: 8335665. DOI: 10.1111/jcmm.16676. View

13.

Shahidian L, Haas M, Le Gras S, Nitsch S, Mourao A, Geerlof A . Succinylation of H3K122 destabilizes nucleosomes and enhances transcription. EMBO Rep. 2021; 22(3):e51009. PMC: 7926236. DOI: 10.15252/embr.202051009. View

14.

Kaya-Okur H, Wu S, Codomo C, Pledger E, Bryson T, Henikoff J . CUT&Tag for efficient epigenomic profiling of small samples and single cells. Nat Commun. 2019; 10(1):1930. PMC: 6488672. DOI: 10.1038/s41467-019-09982-5. View

15.

Kaya-Okur H, Janssens D, Henikoff J, Ahmad K, Henikoff S . Efficient low-cost chromatin profiling with CUT&Tag. Nat Protoc. 2020; 15(10):3264-3283. PMC: 8318778. DOI: 10.1038/s41596-020-0373-x. View

16.

Zhang B, Lin J, Zhang J, Wang X, Deng X . Integrated Chromatin Accessibility and Transcriptome Landscapes of 5-Fluorouracil-Resistant Colon Cancer Cells. Front Cell Dev Biol. 2022; 10:838332. PMC: 8891516. DOI: 10.3389/fcell.2022.838332. View

17.

Liu B, Xu Q, Wang Q, Feng S, Lai F, Wang P . The landscape of RNA Pol II binding reveals a stepwise transition during ZGA. Nature. 2020; 587(7832):139-144. DOI: 10.1038/s41586-020-2847-y. View

18.

Langmead B, Salzberg S . Fast gapped-read alignment with Bowtie 2. Nat Methods. 2012; 9(4):357-9. PMC: 3322381. DOI: 10.1038/nmeth.1923. View

19.

Li H, Handsaker B, Wysoker A, Fennell T, Ruan J, Homer N . The Sequence Alignment/Map format and SAMtools. Bioinformatics. 2009; 25(16):2078-9. PMC: 2723002. DOI: 10.1093/bioinformatics/btp352. View

20.

Zhang Y, Liu T, Meyer C, Eeckhoute J, Johnson D, Bernstein B . Model-based analysis of ChIP-Seq (MACS). Genome Biol. 2008; 9(9):R137. PMC: 2592715. DOI: 10.1186/gb-2008-9-9-r137. View